Molbio Diagnostics.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
One to three months ago
-
The World Health Organization endorsed new TB diagnostics developed by Molbio Diagnostics.Some support2 reports
-
Molbio Diagnostics' share price dropped 2% despite profit growth, while the company also completed a manufacturing capacity expansion program.Some support1 report
-
Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.Some support1 report
-
Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.Some support6 reports
-
Molbio Diagnostics launched its IPO on August 5, 2026, alongside the Dhoot Transmission issue.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Molbio Diagnostics this week
News at the entities that move Molbio Diagnostics most-
Goldman Sachs TransactionalGoldman Sachs projects high demand for AI infrastructure while Wall Street views a potential SpaceX and Tesla merger as inevitable.Moves Molbio Diagnostics
-
International Finance Corporation TransactionalDangote Group hosted an ECOWAS meeting in Lagos, where the bloc sought IFC funding for various projects.Moves Molbio Diagnostics
-
World Health Organization StructuralThe World Health Organization provided data detailing air pollution health risks across Cebu province.Moves Molbio Diagnostics
-
Bengaluru StructuralRecruitment malpractice occurred in the state of Karnataka.Moves Molbio Diagnostics
-
Motilal Oswal Mentioned togetherMotilal Oswal applied for shares in a rights issue on October 22, 2026.Moves Molbio Diagnostics
-
Southeast Asia Shared contextBeijing is expanding its military and strategic footprint across Southeast Asia.Moves Molbio Diagnostics
Connections
The 12 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Goldman Sachs Transactional
Goldman Sachs invested in Molbio Diagnostics during its Initial Public Offering.
-
International Finance Corporation Transactional
IFC invested in Molbio Diagnostics during its Initial Public Offering.
-
Tempsens Mentioned together
Both companies were noted for exhibiting strong performance during their IPOs.
-
Africa Shared context
Molbio Diagnostics operates within the geographical and market context of the African continent.
-
World Health Organization Structural
The World Health Organization formally endorsed TB diagnostics produced by Molbio Diagnostics.
-
Bengaluru Structural
Molbio Diagnostics is establishing an R&D facility within the geographical boundaries of Bengaluru.
-
Motilal Oswal Mentioned together
Molbio Diagnostics is co-mentioned with Motilal Oswal in articles discussing its IPO launch.
-
Motilal Oswal Group Mentioned together
Co-mentioned in the context of fund management activities of Motilal Oswal Group.
Show all 12 connections
-
Goa Shared context
Molbio Diagnostics is located in the state of Goa.
-
Southeast Asia Shared context
Molbio Diagnostics is operating within the geographical context of Southeast Asia.
-
Latin America Shared context
Molbio Diagnostics operates within the regulatory context of Latin America.
-
GMP Mentioned together
Evidence is insufficient to establish a relationship between Molbio Diagnostics and GMP; only GMP's IPO interest was noted.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 events- Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.
- Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.
- Molbio Diagnostics launched its IPO on August 5, 2026, alongside the Dhoot Transmission issue.